ClinicalTrials.gg

Program

AZD7798

A development code.

Its studies are mostly in Crohn Disease, led by AstraZeneca.

Furthest: phase 2, since May 8, 20245 company-led studies, 2 open or running

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
AstraZeneca52 open or runningphase 2since May 8, 2024Jul 6, 2022none ahead
  • Named in AstraZeneca’s own pipeline as AZD7798, phase 2, as of Oct 30, 2026 (source).

Also a collaborator on its studies: parexel.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Jul 6, 2022First study: phase 1 study in Crohn DiseaseFirst studyNCT05452304 · 112 enrolled · United Kingdom
  2. Aug 30, 2023Phase 1 study in Crohn DiseaseNCT06053424 · 13 enrolled · Sweden
  3. May 8, 2024Phase 2 study in Crohn DiseaseNCT06450197 · 120 enrolled · United States, Argentina, Australia and more
  4. May 22, 2024Phase 1 study in Crohn DiseaseNCT06432764 · 9 enrolled · Sweden
  5. Sep 25, 2024Phase 2 study in Crohn DiseaseNCT06681324 · 24 enrolled · Belgium, Italy, Netherlands and more

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 5 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT06681324Crohn Disease · Belgium, Italy, Netherlands and more2Active, not recruitingAug 10, 202624
NCT06432764Crohn Disease · Sweden1CompletedMar 27, 20269
NCT06450197Crohn Disease · United States, Argentina, Australia and more2Active, not recruitingApr 30, 2026120
NCT06053424Crohn Disease · Sweden1CompletedOct 8, 202413
NCT05452304Crohn Disease · United Kingdom1CompletedNov 14, 2024112

How it is read

Names in the registry

  • “AZD7798”, 5 entries

Codes read as this program: AZD7798.

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.